Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:22:59 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



News for C:MYCO from 2023-04-27 to 2024-04-26 - 32 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-04-25 18:51C:MYCOMydecine Innovations Group Inc (2)0.02News ReleaseMydecine to restate 2022 financials, applies for MCTO
2024-04-15 17:24C:MYCOMydecine Innovations Group Inc (2)0.015News ReleaseMydecine closes two debt settlement agreements
2024-04-08 16:11C:MYCOMydecine Innovations Group Inc (2)0.02News ReleaseMydecine arranges shares for debt deals
2024-03-27 19:07C:MYCOMydecine Innovations Group Inc (2)0.02News ReleaseMydecine Innovations closes shares-for-debt deal
2024-03-20 17:16C:MYCOMydecine Innovations Group Inc (2)0.015News ReleaseMydecine arranges $50,000 shares for debt settlement
2024-02-22 16:15C:MYCOMydecine Innovations Group Inc (2)0.013News ReleaseMydecine closes $52,370 debt settlement
2024-02-07 17:11C:MYCOMydecine Innovations Group Inc (2)0.015News ReleaseMydecine receives MYCO-005, -006 notices of allowance
2024-02-05 03:03C:MYCOMydecine Innovations Group Inc (2)0.015News ReleaseMydecine to issue 2.61M shares for debt of $52,370
2024-02-02 16:11C:MYCOMydecine Innovations Group Inc (2)0.02News ReleaseMydecine's Stevenson-Moore resigns as director
2023-12-18 09:17C:MYCOMydecine Innovations Group Inc (2)0.105News ReleaseMydecine receives notice of allowance for MYCO-005
2023-11-28 16:35C:MYCOMydecine Innovations Group Inc (2)0.12News ReleaseMydecine clarifies statements on special access program
2023-11-16 02:05C:MYCOMydecine Innovations Group Inc (2)0.135SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-16 01:58C:MYCOMydecine Innovations Group Inc (2)0.135SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-10-31 11:45C:MYCOMydecine Innovations Group Inc (2)0.12News ReleaseMydecine files prospectus supplement; issues shares
2023-10-26 11:17C:MYCOMydecine Innovations Group Inc (2)0.145News ReleaseMydecine talks drug discovery work with API
2023-10-10 12:00C:MYCOMydecine Innovations Group Inc (2)0.175News ReleaseMydecine completes admission to AQSE
2023-10-05 17:17C:MYCOMydecine Innovations Group Inc (2)0.14News ReleaseMydecine Innovations to trade on CSE Oct. 6
2023-10-05 14:25C:MYCOMydecine Innovations Group Inc (2)0.135New ListingMydecine Innovations to trade on CSE Oct. 6
2023-10-04 19:38C:MYCOMydecine Innovations Group Inc (2)0.135MiscellaneousMydecine Innovations to be delisted from Neo
2023-09-27 17:30C:MYCOMydecine Innovations Group Inc (2)0.13News ReleaseMydecine Innovations to trade in U.K. starting Oct. 10
2023-09-19 16:12C:MYCOMydecine Innovations Group Inc (2)0.19News ReleaseMydecine closes $3.75M prospectus supplement offering
2023-09-15 17:41C:MYCOMydecine Innovations Group Inc (2)0.185News ReleaseMydecine files prospectus supplement for offering
2023-08-30 16:09C:MYCOMydecine Innovations Group Inc (2)0.195News ReleaseMydecine receives conditional approval to list on CSE
2023-08-15 02:34C:MYCOMydecine Innovations Group Inc (2)0.18News ReleaseMydecine has June 30 cash position of $40,458
2023-08-14 19:08C:MYCOMydecine Innovations Group Inc (2)0.18SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-21 17:42C:MYCOMydecine Innovations Group Inc (2)0.17News ReleaseMydecine director Heinzl resigns
2023-07-05 16:34C:MYCOMydecine Innovations Group Inc (2)0.22News ReleaseMydecine shareholders approve all matters at AGSM
2023-05-29 20:01C:MYCOMydecine Innovations Group Inc (2)0.31News ReleaseMydecine closes $500K 1st tranche; adds Heinzl director
2023-05-16 16:17C:MYCOMydecine Innovations Group Inc (2)0.34News ReleaseMydecine spends $143,334 on R&D in Q1
2023-05-15 19:31C:MYCOMydecine Innovations Group Inc (2)0.34SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-15 19:31C:MYCOMydecine Innovations Group Inc (2)0.34SEDAR MD & ASEDAR MD & A
2023-05-10 17:13C:MYCOMydecine Innovations Group Inc (2)0.37News ReleaseMydecine shareholders elect three directors at AGM